Both in Pharmaceuticals
MetaVia vs Moleculin Biotech
Over the past year MTVA returned −89.8% and MBRX returned −97.0%; their daily moves had a correlation of -0.02.
MTVA −89.8% MBRX −97.0%Growth of $1, one year, split-adjusted
| Metric | MTVA | MBRX |
|---|---|---|
| Price | $1.12 | $7.90 |
| Market cap | $7.4M | $8.1M |
| Today | −5.88% | −9.40% |
| 1 month | −27.3% | −21.6% |
| 6 months | −22.2% | −84.3% |
| Year to date | −86.7% | −88.1% |
| 1 year | −89.7% | −96.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.8M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 61.9% | 850.8% |
| Short % of float | 2.9% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).